The role of megatherapy with autologous bone marrow rescue in solid tumours of childhood

Annals of Oncology

Volumn 4, Issue SUPPL. 1, 1993, Pages 45-58

  Ladenstein, R ^a   Hartmann, O ^a   Pinkerton, C R ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; BUSULFAN; CARBOPLATIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DAUNORUBICIN; ETOPOSIDE; MELPHALAN; METHOTREXATE; PROCARBAZINE; TENIPOSIDE; THIOTEPA; VINCRISTINE; VINDESINE;

ADOLESCENT; BRAIN TUMOR; CHILD; CHILDHOOD CANCER; CONFERENCE PAPER; DRUG TOXICITY; EWING SARCOMA; FEMALE; HUMAN; INFANT; MALE; NEPHROBLASTOMA; RHABDOMYOSARCOMA;

EID: 0027324922     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/4.suppl_1.s45     Document Type: Conference Paper

References (67)

1. Patte C. Philip T. Rodary C. Improved survival rate in children with stage III and IV B cell non-Hodgkin’s lymphoma and leukaemia using multi-agent chemotherapy: Results of a study of 114 children from the French Pediatric Oncology Society J Clin Oncol 8 1986 1219 1226
2. Frei E. Canellos G.P. Dose: A critical factor in cancer chemotherapy Am J Med 69 1979 585 594
3. Kushner B.H. Helson L. Coordinated used of sequentially escalated cyclophosphamide and cell-cycle-specific chemotherapy (N4SE protocol) for advanced neuroblastoma: Experience with 100 patients J Clin Oncol 5 1987 1746
4. Jurgens H. Exner U. Kuhl J. High-dose ifosfamide with mesna uroprotection in Ewing’s sarcoma Cancer Chemother Pharmacol 24 1989 S40 S44
5. United Kingdom Children’s Cancer Study Group (unpublished data)
6. Clifford P. Clift R.A. Duff J.K. Nitrogen mustard therapy combined with autologous marrow infusion Lancet i 1961 687 690
7. McFarland W. Granville N.B. Damesheck W. Autologous bone marrow infusion as an adjunct in therapy of malignant disease Blood 14 1959 503 521
8. McElwain T.J. Hedley D.W. Gordon M.Y. High-dose melphalan and non-cryopreserved autologous bone marrow treatment of malignant melanoma and neuroblastoma Exp Hematol 7 Suppl. 5 1979 360 371
9. Hartmann P. Pein F. Philip T. The effects of high-dose polychemotherapy with autologous bone marrow transplantation in 18 children with relapsed lymphoma Eur J Cancer Clin Oncol 18 1982 1044 1045
10. Philip T. Pinkerton R. Hartmann O. The role of massive therapy with autologous bone marrow tranplantation in Burkett’s lymphoma Clin Haematol 15 1 1986 205 217
11. Kellie S. Kingston J. Ovarian failure after high-dose melphalan in adolescents Lancet i 1987 1425
12. De Sanctis V. Galimberti M. Lucarelli G. Gonadal function after allogenic bone marrow transplantation for thalassaemia Arch Dis Childh 66 1991 517 520
13. Hartmann O. Oberlin O. Lemerle J. Acute leukaemia in two patients treated with high-dose melphalan and autologous marrow transplantation for malignant solid tumours J Clin Oncol 2 1984 1424 1425
14. Hawkins M.M. Kinnier Wilson L.M. Stovall M.A. Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer BMJ 304 1992 951 958
15. Appelbaum F.R. Deisseroth A.B. Graw R.G. Prolonged complete remission following high dose chemotherapy of Burkitt’s lymphoma in relapse Cancer 41 1978 1059 1063
16. Miser J.S. Kinsella T.J. Triche T.J. Preliminary results of treatment of Ewing’s sarcoma of bone in children and young adults: Six months of intensive combined modality therapy without maintenance J Clin Oncol 6 1988 484 490
17. August C.S. Serota F.T. Koch P.A. Treatment of advanced neuroblastoma with supralethal chemotherapy, radiation, and allogeneic or autologous marrow reconstitution J Clin Oncol 2 1984 609 616
18. Kinsella T.J. Glaubiger D. Diesseroth A. Intensive combined modality therapy including low dose TBI in high risk Ewing’s sarcoma patients Int J Radiat Oncol Biol Phys 9 1983 1955 1960
19. Miser J.S. Autologous bone marrow transplantation for the treatment of sarcomas Johnson F.L. Pochedly C. Bone marrow transplantation in children 1990 Raven Press Ltd New York
20. Deacon J.M. Wilson P.A. Peckham M.J. The radiobiology of human neuroblastoma Radiother Oncol 3 1985 201 209
21. Pinkerton C.R. Where next with therapy in advanced neuroblastoma? Br J Cancer 61 1990 351 353
22. Philip T. Ghalie R. Pinkerton C.R. A phase II study of high dose cisplatin and VP16 in neuroblastoma: A report from the Societe Francaise d’Oncologie Pediatrique J Clin Oncol 5 1987 941 950
23. Hartmann O. Pinkerton C.R. Philip T. Very high dose cisplatin and etoposide in children with untreated advanced neuroblastoma J Clin Oncol 6 1988 44 50
24. Hartmann O. Vassal G. Valteau D. Autologous bone marrow transplantation in pediatric solid tumors: Phase II studies Bone Marrow Transplant 7 3 1991 106 111
25. Williams T.E. Shahrokh Safarimaryaki. Bone marrow transplantation for treatment of solid tumors Johnson F.L. Pochedly C. Bone marrow transplantation in children 1990 Raven Press New York 221 242
26. Pritchard J. Germond S. Jones D. is high dose melphalan of value in treatment of advanced neuroblastoma? Proc ASCO 5 1986 A 805
27. Pinkerton C.R. ENSG 1 — Randomised study of high-dose melphalan in neuroblastoma Bone Marrow Transplant 7 3 1991 112 113
28. Pinkerton C.R. Philip T. Biron P. High-dose melphalan, vincristine, TBI with autologous marrow transplantation in children with relapsed neuroblastoma — phase II study Med Ped Oncol 15 1987 236 240
29. Philip T. Bernard J.L. Zucker J.M. High dose chemotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: An unselected group of stage IV patients over one year of age J Clin Oncol 5 1987 266 271
30. Treleaven J.G. Gibson F.M. Ugelstat J. Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres Lancet i 1984 70 73
31. Hartmann O. Benhamou E. Beaujean F. Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma J Clin Oncol 5 1987 1205 1211
32. Hartmann O. Benhamou E. Beaujean F. High-dose busulphan and cyclophosphamide with autologous bone marrow transplantation support in advanced malignancies in children: A phase II study J Clin Oncol 4 1986 1804 1810
33. Graham-Pole J. Casper J. Elfenbein G. High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma: A pediatric Oncology Group Study J Clin Oncol 9 1991 152 158
34. Dini G. Lanino E. Garaventa A. Myeloablative therapy and unpurged autologous bone marrow transplantation for poor-prognosis neuroblastoma: Report of 34 cases J Clin Oncol 6 1991 962 969
35. Corbett R. Pinkerton R. Pritchard J. Pilot study of high-dose vincristine, etoposide, carboplatin and melphalan with autologous bone marrow rescue in advanced neuroblastoma Eur J Cancer 28A 1992 1324 1328
36. Gordon S.J. Pearson A.D.J. Reid M. Toxicity of single-day high-dose vincristine, melphalan, etoposide and carboplatin consolidation with autologous bone marrow rescue in advanced neuroblastoma Eur J Cancer 28A 1992 1319 1323
37. Emminger W. Emminger-Schmidmeier W. Hawliczek R. High-dose melphalan, etoposide ± carboplatin (MEC) combined with 12-gray fractionated total-body irradiation in children with generalizd solid tumors Ped Hem Oncol 8 1991 13 22
38. Philip T. Zucker J.M. Bernard P. Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: Is cure possible in a small subgroup? J Clin Oncol 9 1991 1037 1044
39. Graham-Pole J. Is there an advantage to allogeneic over autologous marrow transplantation in patients with metastatic neuroblastoma? Proc 18th Meeting, International Society of Experimental Hematology, Paris 586 1989
40. Graham-Pole H.L. Evans A.E. Siegel S.E. Prognostic importance of serum ferritin in patients with stages III and IV neuroblastoma: The Children’s Cancer Study Group Experience Cancer Res 45 1985 2843 2848
41. Negrier S. Ranchere J.Y. Philip I. Intravenous interleukin-2 just after high dose BCNU and autologous bone marrow transplantation. Report of a multi-centric French pilot study Bone Marrow Transplant 8 1991 259 264
42. Bagnulo S. Perez D.J. Barrett A. High dose melphalan and autologous bone marrow transplantation for solid tumours in childhood Eur J Paed Haem Oncol 1 1985 129
43. Ekert H. Ellis W.M. Waters K.D. Autologous bone marrow rescue in the treatment of advanced tumors of childhood Cancer 49 3 1982 603 609
44. Houghton J.A. Cook R.L. Pamela J.L. Melphalan: A potential new agent in the treatment of childhood rhabdomyosarcoma Cancer Treat Rep 69 1985 91 96
45. Belasco J.B. Mitchell C.D. Rohrbaugh T. Iv melphalan in children Cancer Treat Rep 71 1987 1277 1278
46. Pinkerton C.R. Groot-Loonen J. Barrett A. Rapid VAC, high dose melphalan regimen. A novel chemotherapy approach in childhood soft tissue sarcomas B J Cancer 64 1991 381 385
47. Raney B. Tefft M. Maurer H.M. Disease patterns and survival rate in children with metastatic soft-tissue sarcoma Cancer 62 1988 1257 1266
48. Koscielniak E. Rodary C. Flamant F. Metastatic rhabdomyosarcoma and histologically similar tumors in childhood: A retrospective European multi-centre analysis Med Ped Oncol 20 1992 209 214
49. Pinkerton C.R. Megatherapy for soft tissue sarcomas. EBMT experience Bone Marrow Transplant 7 3 1991 120 122
50. Miser J.S. Autologous bone marrow transplantation for the treatment of sarcomas Johnson F.L. Pochedly C. Bone marrow transplantation in children 1990 Raven Press New York 289 299
51. Hartmann O. Oberlin O. Beaujean F. Place de la chimiotherapie à hautes doses suivie d’autogreffe medullaire dans le traitement des sarcomes d’Ewing metastatiques de I’enfant Bull Cancer 77 1990 181 187
52. Phillips M.B. Pinkerton C.R. High dose busulphan/melphan in paediatric malignancy Med Ped Oncol 19 1991 399 400
53. Phillips G.L. Wolff S.N. Fay J.W. Intensive 1, 3-bis (2-chloroethyl)-l-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma J Clin Oncol 4 5 1986 639 645
54. Biron P. Mornex F. Vial C. Pilot study of high-dose carmustine, transplantation, radiotherapy, and surgery for patients with glioma Dicke K.A. Spitzer G. Jagannath S. Autologous bone marrow transplantation. Proceedings of the Third International Symposium 1987 549 556
55. Postmus P.E. Holthuis J.J.M. Haaxma-Reiche H. Penetration of VP16-213 into cerebrospinal fluid after high-dose intravenous administration J Clin Oncol 2 3 1984 215 220
56. Saarinen U.M. Hovi L. Makipernaa A. High-dose thiotepa with autologous bone marrow rescue in pediatric solid tumors Bone Marrow Transplant 8 1991 369 376
57. Finlay J. August C. Packer R. High-dose chemotherapy with autologous marrow ‘rescue’ in children with recurrent brain tumors Proc ASCO 8 1989 89
58. Groot-Loonen J.J. Pinkerton C.R. Morris-Jones P.H. How curable is relapsed Wilms’ tumour? Arch Dis Child 65 1990 968 970
59. Garaventa A. Hartmann O. Bernard J.L. ABMT for Wilms’ tumor EBMT experience Bone Marrow Transplant 7 1991 118 119
60. Baumgartner C. Bleher E.A. Del Re G. Autologous bone marrow transplantation in the treatment of children and adolescents with advanced malignant tumours Med Paed Oncol 12 1984 104 111
61. Biron P. Philip T. Maraninchi D. Massive chemotherapy and ABMT in progressive disease of non seminomatous testicular cancer Dicke K. Spitzer G. Zander A.R. Autologous bone marrow transplantation 1985 University of Texas Houston 203 210
62. Miser J.S. Autologous bone marrow transplantation for the treatment of sarcomas Johnson F.L. Pochedly C. Bone marrow transplantation in children 1990 Raven Press Ltd New York
63. Ekert H. Ellis W.M. Waters K.D. Autologous bone marrow rescue in the treatment of advanced tumours of childhood Cancer 49 1982 603 609
64. Kempshead J.T. Pritchard J. Neuroblastoma: Recent developments and current challenges Cancer Surveys 3 1984 691 708
65. Cheung N.V. von Hoff D.D. Strandjorel S.E. Detection of neuroblastoma cells in bone marrow using GD2 specific monoclonal antibodies J Clin Oncol 4 1986 363 369
66. Glorieux P. Bouffet E. Biron P. Metastatic interstitial pneumonitis after autologous bone marrow transplant Cancer 58 1986 2136 2139
67. Rill D.R. Buschle M. Foreman C. Retrovirus-mediated gene transfer as an approach to analyze neuroblastoma relapse after autologous bone marrow transplantation Human Gene Therapy 3 1992 129 136